Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study von Ramalingam, S.S., Cheng, Y., Zhou, C., Ohe, Y., Imamura, F., Cho, B.C., Lin, M.-C., Majem, M., Shah, R., Rukazenkov, Y., Todd, A., Markovets, A., Barrett, J.C., Chmielecki, J., Gray, J.

Volltext

Mathematical Modelling of Friction Winding of Large-Dia Meter Packages on a Translationally Moving Hanger von Mironov, A. V., Mazin, L. S., Markovets, A. V., Rokotov, N. V.

Volltext

Mathematical Modeling of Yarn Winding Tension von Rokotov, N. V., Markovets, A. V., Kolesnikov, V. A., Usov, A. G.

Volltext

Molecular landscape of osimertinib resistance revealed by targeted panel sequencing and patient-derived cancer models in non-small cell lung cancer patients von Hong, M.H., Kim, M.H., Kim, S.-Y., Heo, S.G., Kang, H.-N., Park, C.-W., Barrett, J.C., Stetson, D., Chmielecki, J., Markovets, A., Kim, H.R., Cho, B.C.

Volltext

Analysis of cancer metabolism with high-throughput technologies von Markovets, Aleksandra A, Herman, Damir

Volltext

Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study von Cho, B.C., Cheng, Y., Zhou, C., Ohe, Y., Imamura, F., Lin, M.-C., Majem, M., Shah, R., Rukazenkov, Y., Todd, A., Markovets, A., Barrett, C., Chmielecki, J., Gray, J.E., Ramalingam, S.S.

Volltext

An Experimental Stand for Polystructural Precision Winding von Kolesnikov, V. A., Rokotov, N. V., Bespalova, I. M., Markovets, A. V.

Volltext

A Device for Spiral Winding of Wrapping Bundle of Composite Armature von Rokotov, N. V., Bekker, M. V., Bespalova, I. M., Markovets, A. V.

Volltext

Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models von Eberlein, Catherine A, Stetson, Daniel, Markovets, Aleksandra A, Al-Kadhimi, Katherine J, Lai, Zhongwu, Fisher, Paul R, Meador, Catherine B, Spitzler, Paula, Ichihara, Eiki, Ross, Sarah J, Ahdesmaki, Miika J, Ahmed, Ambar, Ratcliffe, Laura E, O'Brien, Elizabeth L Christey, Barnes, Claire H, Brown, Henry, Smith, Paul D, Dry, Jonathan R, Beran, Garry, Thress, Kenneth S, Dougherty, Brian, Pao, William, Cross, Darren A E

Volltext

Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Non-Small Cell Lung Cancer: TATTON von Hartmaier, Ryan J, Markovets, Aleksandra A, Ahn, Myung Ju, Sequist, Lecia V, Han, Ji-Youn, Cho, Byoung Chul, Yu, Helena A, Kim, Sang-We, Yang, James Chih-Hsin, Lee, Jong-Seok, Su, Wu-Chou, Kowalski, Dariusz M, Orlov, Sergey, Ren, Song, Frewer, Paul, Ou, Xiaoling, Cross, Darren A E, Kurian, Nisha, Cantarini, Mireille, Jänne, Pasi A

Volltext

Filter Element for Purification of Liquids to Remove Mechanical Impurities von Rokotov, N. V., Bespalova, I. M., Mazin, L. S., Markovets, A. V., Kolesnikov, V. A.

Volltext

The analysis of puncheon periodic vibrations of the ultrasonic sewing machines von Kuznetsov, K Y, Markovets, A M, Mazin, L S, Lugantseva, T A

Volltext

Promoter prediction in E. coli based on SIDD profiles and Artificial Neural Networks von Bland, Charles, Newsome, Abigail S, Markovets, Aleksandra A

Volltext

New Take-up Winders for Chemical Fiber Machinery von Mazin, L. S., Martynchik, K. I., Markovets, A. V.

Volltext

514MO Acquired mechanisms of resistance to first-line (1L) osimertinib with or without platinum-based chemotherapy (CT) in EGFR-mutated (EGFRm) advanced NSCLC: Preliminary data fro... von Lee, C.K., Robichaux, J.P., Jänne, P.A., Kim, S-W., Kim, T.M., Kobayashi, K., Planchard, D., Sugawara, S., Yanagitani, N., Yang, T-Y., Markovets, A., Bhetaryia, P., Poole, L., Rukazenkov, Y., Hartmaier, R.J., Yang, J.C-H.

Volltext

1888P 24-month follow up of durvalumab and savolitinib combination in MET-driven clear cell and non-clear cell renal cancer von Jackson-Spence, F., Rodriguez, C. Suarez, Larkin, J., Patel, P., Valderrama, B. Perez, Rodriguez-Vida, A., Mendez Vidal, M.J., Markovets, A., Hartmaier, R.J., Szabados, B.E., Jamal, F., Ackerman, C., Powles, T.B.

Volltext

MA12.03 FLAURA2: Resistance, and Impact of Baseline TP53 Alterations in Patients Treated With 1L Osimertinib ± Platinum-Pemetrexed von Yang, J.C., Robichaux, J., Planchard, D., Kobayashi, K., Lee, C.K., Sugawara, S., Yang, T.-Y., Kim, T.M., Kim, S.-W., Yanagitani, N., Markovets, A., Bhetariya, P.J., Poole, L., Rukazenkov, Y., Hartmaier, R., Jänne, P.A.

Volltext

LBA12 Tumour genomics in patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib in the phase II ELIOS study von Ahn, M-J., Cho, B.C., Pang, Y.K., Voon, P.J., Kim, S-W., De Castro Carpeno, J., Tiseo, M., Li, J., Servidio, L., Sadow, S., Markovets, A., Tang, K.H., Piotrowska, Z.

Volltext

FP16.03 Early Circulating-Tumor DNA EGFR Mutation Clearance in Plasma as a Predictor of Clinical Outcomes in The AURA3 Trial von Ahn, M., Hartmaier, R., Wu, Y., Han, J., Akamatsu, H., John, T., Yang, J.C., Shepherd, F.A., Delmonte, A., Huang, X., Mellemgaard, A., Markovets, A., Chmielecki, J., Ramalingam, S.

Volltext

P76.18 Tissue- and Plasma-Based Landscape of Resistance to Osimertinib von Lim, S.M., Yang, S., Lim, S.B., Heo, S.G., Daniel, S., Markovets, A., Rafati, M., Park, C., Yun, J., Pyo, K., Yun, M.R., Ahn, B., Hong, M.H., Kim, H.R., Cho, B.C.

Volltext